J&J unit begins clinical trial of Incraft stent

04/13/2010 | Clinica (subscription required)

Johnson & Johnson's Cordis unit has begun a nonrandomized trial designed to test the ability of its Incraft stent in treating patients with abdominal aortic aneurysm. The device features an ultra-low-profile delivery system and can be tailored to an individual patient during implantation.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN